Marco van de Weert

Marco van de Weert

Associate Professor

ORCID: 0000-0002-8530-6441

Publication year:
All
1 - 8 out of 8Page size: 500
  1. 2008
  2. Published

    Secondary nucleation and accessible surface in insulin amyloid fibril formation

    Foderà, Vito, Librizzi, F., Jensen, M. G., van de Weert, Marco & Leone, M., 2008, In: Journal of Physical Chemistry B. 112, 12, p. 3853-3858

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Thioflavin T hydroxylation at basic pH and its effect on amyloid fibril detection

    Foderà, Vito, Jensen, M. G., Vetri, V., Librizzi, F., Spagnolo, S., Cornett, Claus, Olsen, L., van de Weert, Marco & Leone, M., 2008, In: Journal of Physical Chemistry. 112, 47, p. 15174-15181

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Drying methods for protein pharmaceuticals

    Maltesen, M. J. & van de Weert, Marco, 2008, In: Drug Discovery Today: Technologies. 5, 2-3, p. 81-88

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Quality by design: Spray drying of insulin intended for inhalation

    Maltesen, M. J., Bjerregaard, S., Hovgaard, L., Havelund, S. & van de Weert, Marco, 2008, In: European Journal of Pharmaceutics and Biopharmaceutics. 70, 3, p. 828-838

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Studies on human insulin adsorption kinetics at an organic-aqueous interface determined using a label-free electroanalytical approach

    Thomsen, A. E., Jensen, H., Jørgensen, Lene, van de Weert, Marco & Østergaard, Jesper, 2008, In: Colloids and Surfaces B: Biointerfaces. 63, 2, p. 243-248

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Immunogenicity of biopharmaceuticals: methods to reduce immunogenicity and biosimilars

    van de Weert, Marco & Møller, E. H., 2008, Immunogenicity of biopharmaceuticals. van de Weert, M. & Møller, E. H. (eds.). 1 ed. New York: Springer, p. 97-111

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Communication

  8. Published

    Preface

    van de Weert, Marco & Møller, E. H., 2008, Immunogenicity of biopharmaceuticals. van de Weert, M. & Møller, E. H. (eds.). 1 ed. New York: Springer, p. v-vi

    Research output: Chapter in Book/Report/Conference proceeding › Preface/postscript › Research

  9. Published

    Protein pharmaceuticals

    van de Weert, Marco & Møller, E. H., 2008, In: Drug Discovery Today: Technologies. 5, 2-3, p. 35-36

    Research output: Contribution to journal › Editorial › Research

ID: 1302800